CreatorsPublishersAdvertisers
View more in
Medical & Biotech

NeuExcell and Spark partner to develop gene therapy for Huntington’s

pharmaceutical-technology.com
 2021-09-07

Cover picture for the articleNeuExcell Therapeutics has entered a partnership with Roche Group member, Spark Therapeutics, to develop safe and efficient gene therapy for Huntington’s disease (HD) patients. As per the agreement, Spark will obtain access to NeuExcell’s neuro-regenerative gene therapy platform, as well as its expertise and will work with the company’s research...

www.pharmaceutical-technology.com

Comments / 0

Comments / 0